In order to ensure the continuity of control measures across the Union, as well as of the compliance with the obligations of the Member States under the 1971 United Nations Convention on Psychotropic Substances and under the 1961 United Nations Single Convention on Narcotic Drugs with regard to 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921), 3,4-methylenedioxypyrovalerone (MDPV) and 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine), this Decision should be without prejudice to the obligations of the Member States relating to the time limit for subjecting those new psychoactive substances to control measures and criminal penalties in their national laws, as set out in Article 2 of Decision 2014/688/EU.
Recital 35, Decision_act (EU) 2015/1875
In forcecited 1×
Judgment of the Court (Third Chamber) of 23 December 2015. European Parliament v Council of the European Union.Decision
On the contrary, it is apparent from recital 35 and Article 2 of the implementing decision that the latter applies ‘without prejudice’ to the obligations stemming from the contested decision as regards the period set for submitting the …
23 Dec 2015 · 62014CJ0595
- celex=32014D0688